I don't think the products will be split off.
Pharma will want the suite of 3, including Permetrex. As some of the conditions can often be misdiagnosed the solutions do cross over. Plus if something works and has a big market Pharma will always take it. They have stacks of money to spend on this type of thing. Why take just one.
MC may get creative and try and keep Permetrex and license it, but I really think Pharma will want it all and will dictate the sale, to a degree.
MC will keep the latest announcement (BTX 1801) and take this to trials. This will be his new baby, the Superbug Killer, because if he can pull that off it could be bigger than the other three combined if proven to be better than antibiotics in multiple infections / diseases.
I'm excited to see what deal/s MC and The Chair put together.
Bot Chart, page-551
-
- There are more pages in this discussion • 14,319 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $689.3M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 37.5¢ | $1.784M | 4.691M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 248028 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 356327 | 6 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |